185 related articles for article (PubMed ID: 38537223)
1. A systems framework for investigating the roles of multiple transporters and their impact on drug resistance.
di San Germano M; Krishnan J
Integr Biol (Camb); 2024 Jan; 16():. PubMed ID: 38537223
[TBL] [Abstract][Full Text] [Related]
2. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
3. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
Wang JQ; Wu ZX; Yang Y; Teng QX; Li YD; Lei ZN; Jani KA; Kaushal N; Chen ZS
J Evid Based Med; 2021 Sep; 14(3):232-256. PubMed ID: 34388310
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
5. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
6. ABC-transporters: implications on drug resistance from microorganisms to human cancers.
Lage H
Int J Antimicrob Agents; 2003 Sep; 22(3):188-99. PubMed ID: 13678820
[TBL] [Abstract][Full Text] [Related]
7. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms.
Blackmore CG; McNaughton PA; van Veen HW
Mol Membr Biol; 2001; 18(1):97-103. PubMed ID: 11396617
[TBL] [Abstract][Full Text] [Related]
8. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
9. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
Choi YH; Yu AM
Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
[TBL] [Abstract][Full Text] [Related]
10. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
Joyce H; McCann A; Clynes M; Larkin A
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
[TBL] [Abstract][Full Text] [Related]
11. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.
Li J; Wang Y; Zhang W; Huang Y; Hein K; Hidalgo IJ
Drug Metab Dispos; 2012 Nov; 40(11):2102-8. PubMed ID: 22855735
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes.
Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Curr Pharm Des; 2013; 19(40):7126-40. PubMed ID: 23829373
[TBL] [Abstract][Full Text] [Related]
13. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration.
Krchniakova M; Skoda J; Neradil J; Chlapek P; Veselska R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365759
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette efflux transporters and MDR in cancer.
Pote MS; Gacche RN
Drug Discov Today; 2023 May; 28(5):103537. PubMed ID: 36801375
[TBL] [Abstract][Full Text] [Related]
17. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
18. Investigating the effects of ABC transporter-based acquired drug resistance mechanisms at the cellular and tissue scale.
Liu C; Krishnan J; Xu XY
Integr Biol (Camb); 2013 Mar; 5(3):555-68. PubMed ID: 23364280
[TBL] [Abstract][Full Text] [Related]
19. Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux.
Willers C; Svitina H; Rossouw MJ; Swanepoel RA; Hamman JH; Gouws C
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1949-1976. PubMed ID: 31292714
[TBL] [Abstract][Full Text] [Related]
20. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]